Sartorius (OTCMKTS:SARTF – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $217.65, but opened at $192.43. Sartorius shares last traded at $192.43, with a volume of 45 shares changing hands.
Sartorius Stock Performance
The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The firm has a market cap of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98. The company’s 50 day moving average is $214.16 and its 200 day moving average is $221.13.
Sartorius Company Profile
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.
Featured Stories
- Five stocks we like better than Sartorius
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
